Matches in Wikidata for { <http://www.wikidata.org/entity/Q99634221> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q99634221 description "artículu científicu espublizáu n'agostu de 2020" @default.
- Q99634221 description "scientific article published on 29 August 2020" @default.
- Q99634221 description "wetenschappelijk artikel" @default.
- Q99634221 description "наукова стаття, опублікована 29 серпня 2020" @default.
- Q99634221 name "Epidermal growth factor (EGF)-based activatable probe for predicting therapeutic outcome of an EGF-based doxorubicin prodrug" @default.
- Q99634221 name "Epidermal growth factor (EGF)-based activatable probe for predicting therapeutic outcome of an EGF-based doxorubicin prodrug" @default.
- Q99634221 type Item @default.
- Q99634221 label "Epidermal growth factor (EGF)-based activatable probe for predicting therapeutic outcome of an EGF-based doxorubicin prodrug" @default.
- Q99634221 label "Epidermal growth factor (EGF)-based activatable probe for predicting therapeutic outcome of an EGF-based doxorubicin prodrug" @default.
- Q99634221 prefLabel "Epidermal growth factor (EGF)-based activatable probe for predicting therapeutic outcome of an EGF-based doxorubicin prodrug" @default.
- Q99634221 prefLabel "Epidermal growth factor (EGF)-based activatable probe for predicting therapeutic outcome of an EGF-based doxorubicin prodrug" @default.
- Q99634221 P1433 Q99634221-F9E8F050-3D6E-4B68-9979-6FDA065E8F72 @default.
- Q99634221 P1476 Q99634221-C8668373-00EA-403B-8E49-D1913E2487CF @default.
- Q99634221 P2093 Q99634221-01CE387B-90A2-4B55-B338-971D7D1FB16C @default.
- Q99634221 P2093 Q99634221-3C14DA4D-5443-438C-8A4E-33BFD6D0B66A @default.
- Q99634221 P2093 Q99634221-66730605-F5DC-4719-93B2-44B7CADC7EBC @default.
- Q99634221 P2093 Q99634221-7A625C7C-8CAD-48F2-9463-A9C28AEEBB87 @default.
- Q99634221 P2093 Q99634221-D046343D-C2B3-45F6-9497-0AEE4F66FF20 @default.
- Q99634221 P304 Q99634221-7EAC0CCB-93AA-459F-8105-1E63E8126235 @default.
- Q99634221 P31 Q99634221-06504F9C-436E-4229-B8BC-150DA3658985 @default.
- Q99634221 P356 Q99634221-4E167AC8-AC56-469B-97CE-AB762318FCBC @default.
- Q99634221 P478 Q99634221-BF665B0C-1B3A-41D0-8009-D9820F670445 @default.
- Q99634221 P50 Q99634221-8F1B2D41-9BAE-46AC-9A82-F292E32666D5 @default.
- Q99634221 P50 Q99634221-94925C29-4A77-4AE6-91E7-03452DA03026 @default.
- Q99634221 P50 Q99634221-A33140C4-5DF4-476C-8C94-FA0C8D610AB9 @default.
- Q99634221 P50 Q99634221-A4100EF6-3CA5-44AA-A974-4BA7337A9DB3 @default.
- Q99634221 P50 Q99634221-D09E1F40-E6D2-4A0B-974D-C49EEBD6D0EA @default.
- Q99634221 P577 Q99634221-7AA889D7-8360-4B3D-8806-7A2F2A694A55 @default.
- Q99634221 P698 Q99634221-E70E4C07-937A-4CA5-B377-C593BF9EE12F @default.
- Q99634221 P921 Q99634221-82430DBC-210E-43AA-8995-212B8FD3C340 @default.
- Q99634221 P356 J.JCONREL.2020.08.046 @default.
- Q99634221 P698 32866592 @default.
- Q99634221 P1433 Q6295046 @default.
- Q99634221 P1476 "Epidermal growth factor (EGF)-based activatable probe for predicting therapeutic outcome of an EGF-based doxorubicin prodrug" @default.
- Q99634221 P2093 "Eun Sun Kim" @default.
- Q99634221 P2093 "Han Young Kim" @default.
- Q99634221 P2093 "Ju Hee Ryu" @default.
- Q99634221 P2093 "Sang Hoon Um" @default.
- Q99634221 P2093 "Yejin Sung" @default.
- Q99634221 P304 "222-236" @default.
- Q99634221 P31 Q13442814 @default.
- Q99634221 P356 "10.1016/J.JCONREL.2020.08.046" @default.
- Q99634221 P478 "328" @default.
- Q99634221 P50 Q117256553 @default.
- Q99634221 P50 Q117256555 @default.
- Q99634221 P50 Q117256567 @default.
- Q99634221 P50 Q67123705 @default.
- Q99634221 P50 Q67137782 @default.
- Q99634221 P577 "2020-08-29T00:00:00Z" @default.
- Q99634221 P698 "32866592" @default.
- Q99634221 P921 Q18936 @default.